On the Horizon: New Options for Treating Presbyopia

Pharmaceutical options for treatment of presbyopia will change the conversations between eye care providers and patients. These drugs are also expected to provide a gateway for more patients to visit eye care providers. The current options simply do not completely satisfy all patients.

This program will include engaging discussions among the panel members and audience related to underlying mechanisms of presbyopic changes; pharmacological properties of newly emerging presbyopia-correcting drops and their mechanisms of action; and how presbyopia-correcting drops are likely to affect categories of patients based on individual characteristics.